Sai Phytoceuticals

Sai Phytoceuticals is an Indian pharmaceutical company specializing in the research, development, and manufacturing of niche Active Pharmaceutical Ingredients (APIs), oncology precursors, and herbal-based formulations. Founded in 1995 and headquartered in New Delhi, the company is a prominent supplier of high-quality oncology drugs such as Paclitaxel and Docetaxel, as well as steroid APIs and intermediates. A significant achievement of the company is the development and commercialization of Sailin-HbS, a specialized formulation for the management of Sickle Cell Disease. Operating from a WHO-GMP certified manufacturing facility in Malanpur, Sai Phytoceuticals serves both domestic and international markets, including the US and European Union. The company's expertise spans over four decades in herbal-based molecule research, positioning it as a key player in the integration of natural products with modern pharmaceutical science.